Mesoblast (MEOBF) Form 3 names CFO Obrien as reporting insider
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Mesoblast Ltd filed a Form 3 identifying James Michael Obrien, Chief Financial Officer, as a reporting person for MESO. The filing lists no equity or derivative transactions and shows no buy, sell, acquire, dispose, or other activity in the summarized data.
Positive
- None.
Negative
- None.
FAQ
What does the Mesoblast (MEOBF) Form 3 for James Michael Obrien show?
The Form 3 for Mesoblast lists James Michael Obrien as Chief Financial Officer and a reporting person for MESO. The summarized data shows no buy, sell, acquire, dispose, gift, or restructuring activity and no derivative transactions.
Does the Mesoblast (MEOBF) Form 3 report any option exercises or derivative trades?
The summarized data shows no option exercises or derivative trades. ExerciseCount, exerciseShares, and derivativeTransactionCount are all zero, and the derivativeSummary is empty, indicating no derivative-related activity reported in this Form 3.
Who is the reporting insider in the Mesoblast (MEOBF) Form 3 filing?
The reporting insider is James Michael Obrien, identified as an officer of Mesoblast Ltd with the title Chief Financial Officer. He is not listed as a director or ten percent owner in the structured Form 3 data provided.